LICOSER PLUS 30 TABLETS

Descriptive sheet

LICOSER plus

Food supplement based on serenoa repens, lycopene, camellia sinensis, and urtica dioica; helps maintain the physiological properties of the prostate gland.
It contains no gluten or sugars.
Serenoa Repens (synonym of Sabal Serrulata)
A plant widespread in the United States, Southern Europe, and North Africa. Its main chemical constituents are various sterols, free fatty acids, carotenoids, essential oils, and polysaccharides.
Useful for the proper functioning of the urinary tract and prostate.
Lycopene
A natural pigment belonging to the carotenoid class, it has antioxidant properties similar to those of beta-carotene, but is much more powerful and therefore much more effective at preventing damage from oxygen free radicals. Lycopene is naturally present in tomatoes and other plant substances; with high antioxidant activity, it is considered the most powerful free radical scavenger of the carotenoids.
Urtica Dioica
A perennial herbaceous plant native to Western Asia, widespread throughout temperate regions, including Italy. In modern herbal medicine, the root plays a key role, as it is rich in phytosterols (α-sitosterol, daucosterol, and related glucosides), with a mechanism of action similar to that of Saw Palmetto. It also contains lecithins (scopoletin), which inhibit EGF (Epidermal Growth Factor), a cell growth factor capable of reducing symptoms and partially reducing the size of the gland. Therefore, Urtica Dioica root extract is particularly beneficial for limiting the growth of prostatic tissue induced by androgens, particularly dihydrotestosterone.
Green tea
It is obtained from the leaf buds and young leaves of the plant known by the scientific name "Camellia sinensis." This plant's unique characteristic is its high antioxidant potential.

Ingredients

	per 1 tablet (1300 mg)
Serenoa Repens (dry extract 45% fatty acids)	450 mg
Urtica dioica dry extract (Radix)	300 mg
Green Tea (Catechins)	100 mg
Lycopene	10 mg

How to use
We recommend taking 1 tablet per day before meals for a period of at least 3/4 months.

Warnings
Do not exceed the recommended daily dose. Keep out of reach of children under 3 years of age. Supplements should not be used as a substitute for a varied diet. Pregnant or breastfeeding women and children are advised to consult a doctor.

Format
Pack of 30 tablets of 1,300 mg.

Cod. 1010020.

Bibliography
- Carilla E,Briley M,Fauran F,Sultan C,Duvilliers C. Binding of Permixon, a new treatment for prostatic benign hyperplasia, to the cytosolic androgen receptor in the rat prostate.J Steroid Biochem 1984;20:521-3.
- Champault G, Patel JC, Bonnard QAM. A double-blind trial of an extract of the plant Serenoa repens in benign prostatic hyperplasia.Br J Clin Pharmacol 1984;18:461-2.
- De Bruyne F. et al. Evaluation of the clinical benefit Serenoa Repens and Tamsulosin in severe BPH patients-Personal study subset analysis.Eur.Urol. 2004 Jun;45(6):773-9;Discussion 779-80,2004.
- Boyle P, Robertson C, Lowe F, Roehrborn C. Meta-analysis of clinical trials of Permixon in the treatment of symptomatic benign prostatic hyperplasia. Urology 2000;55:533-9.
- Bent S. et al. Saw Palmetto for benign prostatic hyperplasia. N.Engl.J. Med. 354(6):557-66,2006.
- Wilt T,Ishani A,Stark G,Mac donald R,Mulrow C,Lau J.Serenoa repens for benign prostatic hyperplasia.Cochrane Database Syst Rev 2000;2:CD001423.
- Fong YK, Milani S, Djavan B, Role of phytotherapy in men with lower urinary tract symptoms. Curr opinion urol.2005; 15(1); 45-48.
- Wilt T, Ishani A, Mac Donald R, Serenoa repens for benign prostatic hyperplasia. Cochrane Database Syst Rev,2002; 3; CDCD001423.
- Strauch G, Perles P, Vergult G, et al. Comparison of finasteride and Serenoa repens in the inhibition of 5-alpha reductase in healthy male volunteers. Eur.Urology 1994; 26:3, 247-252.
- Debruyne F, Boyle P, Calais da Silva F, Gillenwater JG, Hamdy FC, Perrin P, Teillac P, Vela-Navarrete R, Raynaud JP, Schulman C, Evaluation of the clinical benefit of permixon and tamsulosin in severe BPH patients- PERMAL study subset analysis. Prog Urol, 2004 Jun;14(3):326-331.
- Avins AL et al. A detailed safety assessment of a Saw Palmetto extract. Complement ther med. 16(3):147-154,2008.
- Levy J.,Bosin E. Et al.,Lycopene is a more potent inhibitor of human cancer cell proliferation than either a-carotene or b-carotene.Nutr. Cancer,1995;24: 257-266.
- Sökeland J. Combined sabal and urtica extract compared with finasteride in men with benign prostatic hyperplasia: analysis of prostate volume and therapeutic outcome. BJU ext 200; 86(4):439-442.
- Schneider T, Rubben H, Stinging nettle root extract in long-term treatment of benign prostatic syndrome (BPS). Results of a randomized, double-blind, placebo controlled multicenter study after 12 months. Urologe A, 2004; 43(3): 302-306.
- Lichius JJ, The inhibiting effects of components of stinging nettle roots on experimentally induced prostatic hyperplasia in mice. Planta Med,1999;65,7: 666-668.
- Bombardelli E, Morazzoni P, Urtica Dioica L. Phytotherapy 1997; 68,5, 387-402.
- Chem Pharm, Bulletin 38-1990.
- Kurahashi N, Inoue M, Iwasaki M, Sasazuki S, Tsugane AS, Japan Public Health Center-Based Prospective Study Group. Dairy product, saturated fatty acid, and calcium intake and prostate cancer in a prospective cohort of Japanese men. Cancer Epidemiol Biomarkers Prev, 2008 Apr; 17 (4): 930-937.
- Betuzzi S, Brausi M, Rizzi F, Castagnetti G, Peracchia G, Corti A, Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. cancer Res,2006 Jan 15;66(2): 1234-1240.
- Etminan M, Takkouche B, Caamano-Isorna F The role of tomato products and lycopene in the prevention of prostate cancer: a meta-analysis of observational studies. Cancer Epidemiol Biomarkers Prev, 2004 Mar; 13 (3): 340-345.
- Michael B. Sporn and Karen T. Liby Is Lycopene an effective Agent for preventing prostate cancer Cancer Prevention Research 03-14-2013.